Drug intelligence / Profile preview

dexamethasone + fludrocortisone

Development stage
Preclinical
Lead developer
Merck
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Intravenous, Oral
01

Overview

Dexamethasone + fludrocortisone is a combination of two synthetic corticosteroids. Dexamethasone is a potent glucocorticoid with strong anti-inflammatory and immunosuppressive properties, while fludrocortisone is primarily a mineralocorticoid used for its salt-retaining effects. This combination has been investigated for use in severe inflammatory conditions such as sepsis and septic shock, where corticosteroid therapy may reduce mortality and improve clinical outcomes by modulating the body's response to systemic infection. Dexamethasone acts mainly through the glucocorticoid receptor to suppress pro-inflammatory gene expression, whereas fludrocortisone acts on the mineralocorticoid receptor to promote sodium retention and maintain vascular tone[1][3][4]. The combination aims to leverage both anti-inflammatory (dexamethasone) and hemodynamic-stabilizing (fludrocortisone) effects.

02

Targets

GR (Glucocorticoid receptor)SMO (Smoothened)MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on dexamethasone + fludrocortisone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexamethasone + fludrocortisone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call